| 25542463
|
Blood MxA protein as a marker for respiratory virus infections in young children. |
J Clin Virol |
2015 |
Toivonen L;Schuez-Havupalo L;Rulli M;Ilonen J;Pelkonen J;Melen K;Julkunen I;Peltola V;Waris M |
View
More |
| 26098566
|
Human rotavirus vaccine (Rotarix): focus on effectiveness and impact 6 years after first introduction in Africa. |
Expert Rev Vaccines |
2015 |
O'Ryan M;Giaquinto C;Benninghoff B |
View
More |
| 26823335
|
A Randomized, Controlled Trial of the Impact of Alternative Dosing Schedules on the Immune Response to Human Rotavirus Vaccine in Rural Ghanaian Infants. |
J Infect Dis |
2016 |
Armah G;Lewis KD;Cortese MM;Parashar UD;Ansah A;Gazley L;Victor JC;McNeal MM;Binka F;Steele AD |
View
More |
| 26823338
|
Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial. |
J Infect Dis |
2016 |
Zaman K;Fleming JA;Victor JC;Yunus M;Bari TI;Azim T;Rahman M;Mowla SM;Bellini WJ;McNeal M;Icenogle JP;Lopman B;Parashar U;Cortese MM;Steele AD;Neuzil KM |
View
More |
| 27260009
|
Incidence of rotavirus gastroenteritis by age in African, Asian and European children: Relevance for timing of rotavirus vaccination. |
Hum Vaccin Immunother |
2016 |
Steele AD;Madhi SA;Cunliffe NA;Vesikari T;Phua KB;Lim FS;Nelson EA;Lau YL;Huang LM;Karkada N;Debrus S;Han HH;Benninghoff B |
View
More |
| 30753368
|
Impact of Rotavirus Vaccine Introduction in Children Less Than 2 Years of Age Presenting for Medical Care With Diarrhea in Rural Matlab, Bangladesh. |
Clin Infect Dis |
2019 |
Schwartz LM;Zaman K;Yunus M;Basunia AH;Faruque ASG;Ahmed T;Rahman M;Sugimoto JD;Halloran ME;Rowhani-Rahbar A;Neuzil KM;Victor JC |
View
More |
| 30785851
|
Immunogenicity and safety of the diphtheria, pertussis, tetanus and inactivated poliovirus vaccine when co-administered with the human rotavirus vaccine (Rotarix) in healthy Japanese infants: a phase IV randomized study. |
Hum Vaccin Immunother |
2019 |
Gillard P;Tamura T;Kuroki H;Morikawa Y;Moerman L;Parra J;Kitamura Y;Mihara K;Okamasa A |
View
More |
| 31197662
|
Economic Evaluation of Human Rotavirus Vaccine in Thailand. |
Infect Dis Ther |
2019 |
Saokaew S;Prasitsuebsai W;Bibera GL;Kengkla K;Zhang XH;Oh KB;Lee C |
View
More |
| 32365189
|
Immunogenicity and safety of porcine circovirus-free human rotavirus vaccine in healthy infants: a phase III, randomized trial. |
J Infect Dis |
2020 |
Salamanca de la Cueva I;Pahud B;Huang LM;Leonardi M;Garcia-Sicilia J;Cespedes J;Abdelnour A;Tamura T;Kuroki H;Chiu NC;Virta M;Kokko S;Horn M;Panzer F;Kim JH;Jin L;Moerman L;Debacq C;Parra J;Ugarte A;Bi D |
View
More |
| 32729747
|
Fifteen years of experience with the oral live-attenuated human rotavirus vaccine: reflections on lessons learned. |
Expert Rev Vaccines |
2020 |
Pereira P;Vetter V;Standaert B;Benninghoff B |
View
More |
| 33077301
|
Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial. |
Vaccine |
2021 |
Abu-Elyazeed R;Klein NP;Moerman L;Povey M;Pruitt A;Senders S;Silas P;Bi D |
View
More |
| 33489932
|
The Complex Interactions Between Rotavirus and the Gut Microbiota. |
Front Cell Infect Microbiol |
2020 |
Kim AH;Hogarty MP;Harris VC;Baldridge MT |
View
More |
| 34187326
|
15-year experience with rotavirus vaccination in Mexico: a systematic literature review. |
Hum Vaccin Immunother |
2021 |
Guzman-Holst A;Ortega-Barria E;Flores AA;Carreno-Manjarrez R;Constenla D;Cervantes-Apolinar MY |
View
More |
| 34428112
|
A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants. |
Hum Vaccin Immunother |
2021 |
Cohet C;Cheuvart B;Moerman L;Bi D;Caplanusi A;Kariyappa M;Lalwani S;Mitra M;Sapru A;Saha S;Varughese PV;Kompithra RZ;Gandhi S |
View
More |
| 35062744
|
Escherichia coli Nissle 1917 Enhances Efficacy of Oral Attenuated Human Rotavirus Vaccine in a Gnotobiotic Piglet Model. |
Vaccines (Basel) |
2022 |
Michael H;Miyazaki A;Langel SN;Amimo JO;Kick MK;Chepngeno J;Paim FC;Fischer DD;Rajashekara G;Saif LJ;Vlasova AN |
View
More |
| 35232596
|
Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study. |
Vaccine |
2022 |
Lau YL;Fan Leung T;Sirvan Cetin B;Cagri Dinleyici E;Huang LM;Halperin SA;Hsiao CC;Tapiero B;Tipton M;Campbell JD;Moerman L;Povey M;Bi D;Singh T |
View
More |
| 36146607
|
Probiotic as Adjuvant Significantly Improves Protection of the Lanzhou Trivalent Rotavirus Vaccine against Heterologous Challenge in a Gnotobiotic Pig Model of Human Rotavirus Infection and Disease. |
Vaccines (Basel) |
2022 |
Parreno V;Bai M;Liu F;Jing J;Olney E;Li G;Wen K;Yang X;Castellucc TB;Kocher JF;Zhou X;Yuan L |
View
More |
| 36507685
|
Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries. |
Hum Vaccin Immunother |
2022 |
Marijam A;Schuerman L;Izurieta P;Pereira P;Van Oorschot D;Mehta S;Ota MO;Standaert B |
View
More |
| 37339232
|
Cost-effectiveness analysis measuring the total costs against the health benefits of three different rotavirus vaccines for Mexico. |
Hum Vaccin Immunother |
2023 |
Gomez J;Velazquez FR;Guzman-Holst A;Cervantes Apolinar MY;Van Bellinghen LA;Van Vlaenderen I;van Oorschot D |
View
More |
